Japan, March 25 -- ACERTA PHARMA BV has got intellectual property rights for 'SOLID FORMS AND FORMULATIONS OF (S)-4-(8-AMINO-3-(1-(BUT-2-YNOYL)PYRROLIDIN-2-YL)IMIDAZO[1,5-A]PYRAZIN-1-YL)-N-(PYRIDIN-2-YL) BENZAMIDE.' Other related details are as follows:

Application Number: JP,2022-096907

Category (FI): A61K31/4985,A61K45/00,A61K47/12,A61K47/22,A61K47/32,A61K47/36,A61P1/14,A61P13/12,A61P17/00,A61P17/06,A61P19/02,A61P21/00,A61P27/02,A61P29/00,A61P29/00,101,A61P3/10,A61P35/00,A61P35/02,A61P37/06,A61P37/08,A61P43/00,121,A61P9/00,A61P9/10,C07D487/04,144

Stage: Grant (IP right document published.)

Filing Date: June 15, 2022

Publication Date: Aug. 17, 2022

The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100

Discl...